Published in Women's Health Weekly, June 13th, 2002
Presented were results of a phase I/II dose escalation study in which 64 women used Savvy gel in single and multiple doses for 2 weeks. Data from the trial indicated that Savvy met the primary endpoints of safety and acceptability.
Results of the second trial, a phase I/II postcoital testing (PCT) study investigating the safety and spermicidal efficacy of three different concentrations of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly